Skip to main navigation
Skip to search
Skip to main content
Athabasca University Home
Search content at Athabasca University
Home
Researchers
Research Outputs
Research Activities
Datasets
News Media
Research units
Assets and Initiatives
Research Projects
Research Prizes
Impacts
Aerosolized magnesium sulfate for acute asthma: A systematic review
Maurice Blitz
, Sandra Blitz
, Rodney Hughes
, Barry Diner
, Richard Beasley
,
Jennifer Knopp
, Brian H. Rowe
Faculty of Health Disciplines
Research output
:
Contribution to journal
›
Review article
›
peer-review
71
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Aerosolized magnesium sulfate for acute asthma: A systematic review'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Acute Asthma
100%
Magnesium Sulfate
100%
Aerosolized
100%
Confidence Interval
30%
Pulmonary Function
30%
Standardized Mean Difference
20%
Asthma Exacerbation
20%
Relative Risk
20%
Hospitalization Rate
20%
Randomized Controlled Trial
10%
Data Extraction
10%
Cochrane
10%
Airway
10%
MEDLINE
10%
Subgroup Analysis
10%
Embase
10%
CINAHL
10%
Fixed Effects Model
10%
Adult Patients
10%
Treatment Options
10%
Hospital Admission
10%
Lung Function
10%
Methodological Quality
10%
Asthma
10%
Acute Asthma Exacerbation
10%
Combined Search
10%
Inactive Control
10%
Function Improvement
10%
Therapeutic Efficacy
10%
Medicine and Dentistry
Asthma
100%
Lung Function
100%
Magnesium Sulfate
100%
Asthma Exacerbation
66%
Lung
33%
Randomized Controlled Trial
33%
Independent Reviewer
33%
Patient with Asthma
33%
Subgroup Analysis
33%
Treatment Option
33%
Nursing and Health Professions
Magnesium Sulfate
100%
Asthma
100%
Confidence Interval
75%
CINAHL
25%
Emergency Ward
25%
Data Extraction
25%
Independent Reviewer
25%
Efficacy
25%
Patient with Asthma
25%
Immunology and Microbiology
Asthma
100%
Agonist
100%
Lung Function
75%
Asthma Exacerbation
50%
Lung
25%
Cinahl
25%
Data Extraction
25%
Airway
25%
Pharmacology, Toxicology and Pharmaceutical Science
Magnesium Sulfate
100%
Asthma
100%
Randomized Controlled Trial
20%